Zimmer Biomet Holdings Inc (ZBH) : Healthcor Management scooped up 50,000 additional shares in Zimmer Biomet Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Nov 14, 2016. The investment management firm now holds a total of 1,050,000 shares of Zimmer Biomet Holdings Inc which is valued at $102,889,500.Zimmer Biomet Holdings Inc makes up approximately 6.75% of Healthcor Management’s portfolio.
Other Hedge Funds, Including , Arrowstreet Capital Limited Partnership sold out all of its stake in ZBH during the most recent quarter. The investment firm sold 68,800 shares of ZBH which is valued $6,741,712.Qci Asset Management Incny reduced its stake in ZBH by selling 1,464 shares or 1.17% in the most recent quarter. The Hedge Fund company now holds 123,679 shares of ZBH which is valued at $12,740,174. Zimmer Biomet Holdings Inc makes up approx 1.86% of Qci Asset Management Incny’s portfolio.Mechanics Bank Trust Department reduced its stake in ZBH by selling 190 shares or 4.31% in the most recent quarter. The Hedge Fund company now holds 4,220 shares of ZBH which is valued at $510,958. Zimmer Biomet Holdings Inc makes up approx 0.13% of Mechanics Bank Trust Department’s portfolio.Kirr Marbach Co In reduced its stake in ZBH by selling 671 shares or 0.7% in the most recent quarter. The Hedge Fund company now holds 95,115 shares of ZBH which is valued at $12,182,329. Zimmer Biomet Holdings Inc makes up approx 2.45% of Kirr Marbach Co In’s portfolio.Parsec Financial Management boosted its stake in ZBH in the latest quarter, The investment management firm added 2,323 additional shares and now holds a total of 25,354 shares of Zimmer Biomet Holdings Inc which is valued at $3,273,201. Zimmer Biomet Holdings Inc makes up approx 0.30% of Parsec Financial Management’s portfolio.
Zimmer Biomet Holdings Inc closed down -0.16 points or -0.16% at $100.64 with 24,09,857 shares getting traded on Monday. Post opening the session at $101.04, the shares hit an intraday low of $100.555 and an intraday high of $101.96 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Zimmer Biomet Holdings Inc reported $1.79 EPS for the quarter, based on the information available during the earnings call on Oct 31, 2016. Analyst had a consensus estimate of $1.79. The company had revenue of $1832.80 million for the quarter, compared to analysts expectations of $1837.65 million. The company’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.
Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. Shares were Upgraded by Needham on Nov 1, 2016 to ” Strong Buy” and Lowered the Price Target to $ 148 from a previous price target of $150 .
Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.